Accel Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
1,246
+201
+19% +$205K 0.34% 71
2026
Q1
$962K Buy
1,045
+8
+0.8% +$8.11K 0.25% 98
2025
Q4
$1.11M Buy
1,037
+91
+10% +$87K 0.3% 81
2025
Q3
$722K Sell
946
-25
-3% -$18.6K 0.21% 112
2025
Q2
$757K Sell
971
-15
-2% -$11.7K 0.25% 93
2025
Q1
$815K Sell
986
-72
-7% -$59.9K 0.29% 82
2024
Q4
$817K Buy
1,058
+45
+4% +$37.3K 0.31% 80
2024
Q3
$898K Sell
1,013
-3
-0.3% -$2.7K 0.33% 75
2024
Q2
$920K Buy
1,016
+76
+8% +$60.8K 0.37% 71
2024
Q1
$731K Buy
940
+56
+6% +$39.9K 0.31% 80
2023
Q4
$515K Buy
884
+60
+7% +$35K 0.26% 99
2023
Q3
$443K Buy
824
+146
+22% +$75.2K 0.25% 97
2023
Q2
$318K Buy
678
+485
+251% +$203K 0.18% 118
2023
Q1
$66.3K Buy
193
+6
+3% +$2.02K 0.03% 417
2022
Q4
$68.4K Buy
187
+57
+44% +$20.2K 0.03% 309
2022
Q3
$43K Hold
130
0.02% 402
2022
Q2
$43K Sell
130
-193
-60% -$57.9K 0.02% 380
2022
Q1
$95K Buy
323
+2
+0.6% +$515 0.05% 263
2021
Q4
$89K Hold
321
0.04% 278
2021
Q3
$74K Buy
321
+100
+45% +$24.7K 0.05% 267
2021
Q2
$51K Hold
221
0.03% 334
2021
Q1
$41K Hold
221
0.03% 349
2020
Q4
$37K Buy
+221
New +$33K 0.03% 355

Other funds holding LLY

Accel Wealth Management's LLY Position: Q2 2026 in Review

Accel Wealth Management increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $205K and bringing the position to 1,246 shares worth $1.5M. The position accounts for 0.34% of the portfolio, ranked #71.

Accel Wealth Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 1,285 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Accel Wealth Management held 1,246 shares of Eli Lilly worth $1.5M as of Q2 2026.
  • Accel Wealth Management bought 201 Eli Lilly shares in Q2 2026, an estimated $205K.
  • Eli Lilly made up 0.34% of Accel Wealth Management's portfolio in Q2 2026, its #71 holding.
  • Accel Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 1,285 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.